TotalSeq™-C1036 anti-mouse CD144 (VE-cadherin) Antibody, CD144, BV13,BioLegend,138021

Clone BV13 recognizes an epitope between aa 45 and 56, and has a binding affinity of 5-15 nM5. Additional reported applications (for relevant formats) include: Western blotting1, blocking of cell interactionsin vivo1, and immunofluorescence microscopystaining4.

Host

Rat

Reactivity

Mouse

Application

PG - Quality tested

Platform ID

BAB087147558

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-C1036 anti-mouse CD144 (VE-cadherin) Antibody, CD144, BV13
Cat. No.138021
HostRat
RRIDAB_3717115 (BioLegend Cat. No. 138021)
IsotypeRat IgG1, κ
ReactivityMouse
ApplicationPG - Quality tested
ClonalityMonoclonal
Clone NumberBV13
Concentration0.5 mg/mL
TargetCD144
ImmunogenVE-cadherin-Ig fusion protein
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD144, also known as vascular endothelial-cadherin (VE-cadherin), is a 120 kD member of the type II Cadherin family.  It is an endothelial specific hemophilic adhesion molecule involved in endothelial cell survival, migration, contact-dependent growth inhibition, and homophilic adhesion.  VE-cadherin is essential for maintaining the integrity of the endothelial barrierin vivo.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.